Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Theranostics|June 28, 2012
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 PentetreotideEbrahim S Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, et al.
The Journal of Rheumatology|October 19, 2010
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5Shervin Assassi, John D Reveille, Frank C Arnett, et al.
Arthritis Care & Research|October 26, 2012
Measuring illness behavior in patients with systemic sclerosisErin L Merz, Vanessa L Malcarne, Scott C Roesch, et al.
Arthritis Research & Therapy|September 4, 2010
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortShervin Assassi, Roozbeh Sharif, Robert E Lasky, et al.
Seminars in Arthritis and Rheumatism|March 25, 2011
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohortRoozbeh Sharif, Maureen D Mayes, Perry M Nicassio, et al.
Annals of the Rheumatic Diseases|March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosisRoozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
The Journal of Rheumatology|May 17, 2011
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysisRoozbeh Sharif, Marvin J Fritzler, Maureen D Mayes, et al.
The Journal of Rheumatology|February 19, 2013
Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trialEmily W Hung, Maureen D Mayes, Roozbeh Sharif, et al.
Pageof 2